Navigation Links
Lexicon Pharmaceuticals to present at the Jefferies 2012 Global Healthcare Conference
Date:5/30/2012

THE WOODLANDS, Texas, May 30, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Brian Zambrowicz, Ph.D., executive vice president and chief scientific officer, will present at the Jefferies 2012 Global Healthcare Conference on Wednesday, June 6 at 11:00 a.m. Eastern Time in New York City. Dr. Zambrowicz will provide an overview of Lexicon's clinical development programs and milestones.

A live webcast of the presentation will be available through Lexicon's corporate website at www.lexpharma.com. An archived version of the presentation will be available for 30 days after the event.

About Lexicon
Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease. Lexicon currently has five drug programs in mid-stage development for diabetes, carcinoid syndrome, irritable bowel syndrome, rheumatoid arthritis and glaucoma, all of which were discovered by Lexicon's research team. Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets. Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs. For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement
This press release contains "forward-looking" statements, including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct preclinical and clinical development of its potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2011, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
3. Lexicon to Provide First Quarter 2012 Financial Results
4. Lexicon Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
5. Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference
6. Lexicon to Report Fourth Quarter and Year End 2011 Financial Results on February 22, 2012
7. Lexicon Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
8. Lexicon Announces Commencement of Rights Offering to Stockholders
9. Lexicon to Present LX4211 Clinical and Preclinical Data at Diabetes Conference
10. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results
11. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... Research and Markets has ... Disposables Market 2016-2020"  report to their offering.  ... global anesthesia disposables market is set to ... the period 2016-2020.  Healthcare-acquired infections ... safety. Organizations like the CDC and Public ...
(Date:4/27/2016)... FRANCISCO , April 27, 2016 ... reach over USD 2.14 billion by 2022, according ... Inc.       (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ... technological advancement affecting the efficiency and accuracy delivered ... the persistent demand for novel urinalysis instruments and ...
(Date:4/27/2016)... April 27, 2016 At the ... launch of a Phase 2 clinical study of its ... patients undergoing cochlear implantation (CI) surgery. This large, placebo-controlled, ... Germany and France ... ear at the time of surgery. "Despite advances in ...
Breaking Medicine Technology:
(Date:4/28/2016)... , ... April 28, 2016 , ... ... today announced it will demonstrate its leading secure mobility workstation suite, SentinelSecure™, at ... Held at Hilton Union Square, this will be MobileIron’s 6th Mobile First Conference ...
(Date:4/28/2016)... ... April 28, 2016 , ... Denise McCormick Baich had written poetry dating back to her childhood, ... much like a tsunami and took on a more spiritual tone. The desire to put ... do more with it than just file it away. Friends would ask her how she ...
(Date:4/28/2016)... ... ... For the 10,000 Americans who turn 65 on any given day, “getting wiser” with ... Now, a new book—Staying Sharp For Dummies (Paper; ISBN: 978-1-119-18779-0; Available Now)—outlines simple things ... from honing your memory and managing stress to eating healthy foods as part of ...
(Date:4/28/2016)... Boston,MA (PRWEB) , ... April 28, 2016 , ... Boston ... U.S Food and Drug Administration (FDA). The treatment consists of the application of Riboflavin, ... of the collagen fibers which in turn strengthens the cornea to slow the progression ...
(Date:4/28/2016)... MA (PRWEB) , ... April 28, 2016 , ... The ... eating patterns based on the latest nutritional science. While there is a lot of ... improve their health, according to the April 2016 issue of Harvard Men's Health ...
Breaking Medicine News(10 mins):